This is list of our ongoing projects

1. Therapeutics role and molecular determinants of GDF11 regulated liver fibrosis (NRPU-2022, PKR 7.8 million)
2. Production of monoclonal antibodies (mAb) using hybridoma technology
3. Production of recombinant monoclonal antibodies (r mAb)
4. Production of polyclonal antibodies (pAb)
5. Study of Chromosomal Disorder by Conventional and FISH-based Technologies
6. Natural bioactive compounds and crude extracts-induced mitochondrial turnover in the mouse model of type 2 diabetes
7. Preventive effect of hydroalcohlic extracts of Rhazya stricta and Arbutus unedo against mouse model of type-II-diabetes
8. Evaluation of in vitro and in vivo antioxidant potential of Nigella sativa and Allium sativum L. extract on the mouse model of type 2 diabetes
9. Antidiabetic potential of hydroalcoholic extracts of Stevia rebaudiana and Andrographis folium in diet induced diabetes mouse model
10. Combined anti-cancer, antioxidant protective effect of “Artemisia Absinthium” and “Citrus Aurantium” extract on Albino mice model of hepatitis.
11. Changes of mitophagy in the liver of mouse model of diabetes 
12. Therapeutic potential of TERT-mediated restriction of mTORC1 for the treatment of liver fibrosis and chronic hepatitis 
13. Therapeutic evaluation of CRISPR/Cas9-mediated knockout and repair of EI24 gene in the breast cancer